Back to Search Start Over

Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease.

Authors :
Monti G
Kjolby M
Jensen AMG
Allen M
Reiche J
Møller PL
Comaposada-Baró R
Zolkowski BE
Vieira C
Jørgensen MM
Holm IE
Valdmanis PN
Wellner N
Vægter CB
Lincoln SJ
Nykjær A
Ertekin-Taner N
Young JE
Nyegaard M
Andersen OM
Source :
Acta neuropathologica communications [Acta Neuropathol Commun] 2021 Mar 16; Vol. 9 (1), pp. 43. Date of Electronic Publication: 2021 Mar 16.
Publication Year :
2021

Abstract

SORL1 is strongly associated with both sporadic and familial forms of Alzheimer's disease (AD), but a lack of information about alternatively spliced transcripts currently limits our understanding of the role of SORL1 in AD. Here, we describe a SORL1 transcript (SORL1-38b) characterized by inclusion of a novel exon (E38b) that encodes a truncated protein. We identified E38b-containing transcripts in several brain regions, with the highest expression in the cerebellum and showed that SORL1-38b is largely located in neuronal dendrites, which is in contrast to the somatic distribution of transcripts encoding the full-length SORLA protein (SORL1-fl). SORL1-38b transcript levels were significantly reduced in AD cerebellum in three independent cohorts of postmortem brains, whereas no changes were observed for SORL1-fl. A trend of lower 38b transcript level in cerebellum was found for individuals carrying the risk variant at rs2282649 (known as SNP24), although not reaching statistical significance. These findings suggest synaptic functions for SORL1-38b in the brain, uncovering novel aspects of SORL1 that can be further explored in AD research.

Details

Language :
English
ISSN :
2051-5960
Volume :
9
Issue :
1
Database :
MEDLINE
Journal :
Acta neuropathologica communications
Publication Type :
Academic Journal
Accession number :
33726851
Full Text :
https://doi.org/10.1186/s40478-021-01140-7